NCT00053794View on ClinicalTrials.gov

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 9, 2003

Primary Completion Date

September 18, 2004

Study Completion Date

September 22, 2008

Conditions
Endometrial CancerSarcoma
Interventions
DRUG

perifosine

Trial Locations (6)

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

V5Z 4E6

British Columbia Cancer Agency - Vancouver Island Cancer Centre, Vancouver

L8V 5C2

Margaret and Charles Juravinski Cancer Centre, Hamilton

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

M5G 1X5

Mount Sinai Hospital - Toronto, Toronto

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NCIC Clinical Trials Group

NETWORK